Thalidomide was first evaluated in patients with refractory multiple myeloma in the mid-90s. Based on the promising results achieved in these patients, the drug was subsequently used in earlier stages of the disease. Meanwhile, numerous phase II studies have been published using different doses and
โฆ LIBER โฆ
Dialysis treatment in multiple myeloma
โ Scribed by I. Taraba; A. Hering
- Publisher
- Springer Netherlands
- Year
- 1985
- Tongue
- English
- Weight
- 257 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thalidomide treatment in multiple myelom
โ
Kathrin Strasser; Heinz Ludwig
๐
Article
๐
2002
๐
Elsevier Science
๐
English
โ 139 KB
Interferons in the treatment of multiple
โ
M. Robert Cooper; Charles E. Welander
๐
Article
๐
1987
๐
John Wiley and Sons
๐
English
โ 631 KB
Interferons in the treatment of multiple
โ
R. Ohno
๐
Article
๐
1987
๐
John Wiley and Sons
๐
French
โ 652 KB
A review of the clinical studies in which interferons have been involved has shown that they may have a role in the treatment of multiple myeloma. Twelve studies, each of which involved at least 10 evaluable cases (352 in total) with various dose schedules involving leukocyte, lymphoblastoid and rec
Radiotherapy in the treatment of multipl
โ
Antonio Bosch; Zenaida Frias
๐
Article
๐
1988
๐
Elsevier Science
๐
English
โ 921 KB
Cyclophosphamide in the treatment of mul
โ
Salokannel, S. J. ;Palva, I. P. ;Timonen, T. ;Kaipainen, W. J.
๐
Article
๐
1971
๐
Springer-Verlag
โ 251 KB
New treatment strategies for multiple my
โ
Dr Raymond Alexanian; Bart Barlogie
๐
Article
๐
1990
๐
John Wiley and Sons
๐
English
โ 520 KB